Mitsubishi UFJ Asset Management’s Integra LifeSciences IART Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35K	Hold	75	–	–	﹤0.01%	1648
2026 Q1	$707	Hold	75	–	–	﹤0.01%	1615
2025 Q4	$901	Hold	75	–	–	﹤0.01%	1620
2025 Q3	$1.07K	Hold	75	–	–	﹤0.01%	1598
2025 Q2	$920	Hold	75	–	–	﹤0.01%	1607
2025 Q1	$1.65K	Hold	75	–	–	﹤0.01%	1585
2024 Q4	$1.74K	Hold	75	–	–	﹤0.01%	1582
2024 Q3	$1.36K	Hold	75	–	–	﹤0.01%	1584
2024 Q2	$2.19K	Hold	75	–	–	﹤0.01%	1555
2024 Q1	$2.66K	Hold	75	–	–	﹤0.01%	1542
2023 Q4	$3.06K	Hold	75	–	–	﹤0.01%	1519
2023 Q3	$2.86K	Buy	+75	New	+$3.15K	﹤0.01%	1523

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Mitsubishi UFJ Asset Management's IART Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management held its Integra LifeSciences (IART) position steady in Q2 2026 at 75 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

Mitsubishi UFJ Asset Management first reported a position in IART in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.06K in Q4 2023. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Mitsubishi UFJ Asset Management held 75 shares of Integra LifeSciences worth $1.35K as of Q2 2026.
Mitsubishi UFJ Asset Management left its Integra LifeSciences share count unchanged in Q2 2026.
Integra LifeSciences made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1648 holding.
Mitsubishi UFJ Asset Management first reported a position in Integra LifeSciences in Q3 2023 and has held it in 12 quarters since.
Mitsubishi UFJ Asset Management's Integra LifeSciences position peaked at $3.06K in Q4 2023.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.